Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.22 USD | +1.76% | +8.21% | -3.51% |
May. 10 | HC Wainwright Adjusts Catalyst Pharmaceuticals' Price Target to $26 From $24, Keeps Buy Rating | MT |
May. 09 | Transcript : Catalyst Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 462M | Sales 2025 * | 543M | Capitalization | 1.92B |
---|---|---|---|---|---|
Net income 2024 * | 117M | Net income 2025 * | 161M | EV / Sales 2024 * | 3.13 x |
Net cash position 2024 * | 469M | Net cash position 2025 * | 700M | EV / Sales 2025 * | 2.24 x |
P/E ratio 2024 * |
17.2
x | P/E ratio 2025 * |
12.6
x | Employees | 167 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.79% |
Latest transcript on Catalyst Pharmaceuticals, Inc.
1 day | +1.76% | ||
1 week | +8.21% | ||
Current month | +7.77% | ||
1 month | +6.57% | ||
3 months | +23.07% | ||
6 months | +28.42% | ||
Current year | -3.51% |
Managers | Title | Age | Since |
---|---|---|---|
Patrick McEnany
FOU | Founder | 76 | 01-12-31 |
Richard Daly
CEO | Chief Executive Officer | 62 | 15-02-18 |
Michael Kalb
DFI | Director of Finance/CFO | 53 | Dec. 31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick McEnany
FOU | Founder | 76 | 01-12-31 |
Donald Denkhaus
BRD | Director/Board Member | 78 | 15-02-18 |
David Tierney
BRD | Director/Board Member | 60 | 02-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.05% | 28 M€ | -1.45% | ||
0.32% | 25 M€ | -2.33% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 16.22 | +1.76% | 1,465,928 |
24-05-10 | 15.94 | +1.85% | 1,437,077 |
24-05-09 | 15.65 | +6.32% | 1,780,987 |
24-05-08 | 14.72 | -2.77% | 1,099,681 |
24-05-07 | 15.14 | +1.00% | 995,078 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.51% | 1.88B | |
-2.10% | 89.08B | |
+2.76% | 40.9B | |
-12.92% | 32.25B | |
+54.69% | 25.14B | |
-16.51% | 15.39B | |
-8.27% | 11.91B | |
-42.60% | 11.89B | |
-12.82% | 11.64B | |
+7.34% | 9.03B |
- Stock Market
- Equities
- CPRX Stock